Skip to content Skip to footer
Subscribe Now
Countries in Health Innovation Top 20 2024
TOP 20

Top 20 Countries in Health Innovation in 2024

Top 20 Countries in Health Innovation in 2024Shots:By leveraging high-quality research, PharmaShots brings a meticulously prepared guide to the Top 20 Countries in Health InnovationUsing quantitative and qualitative analysis of several aspects encompassing healthcare innovations, PharmaShots dedicatedly navigated the core focus areas of innovations in healthcare while considering trending practices like the…
October 10, 2024

Read more

ThoughtSpot_John Cunningham
THOUGHTSPOT

Digital Health Innovations Reshaping the Pharmaceutical Industry

The pharmaceutical industry is undergoing a significant transformation thanks to digital health innovations. These advancements are not only enhancing patient care but also optimizing drug development processes. Understanding these changes is crucial for staying ahead in a competitive market.In recent years, digital health technologies have revolutionized various sectors, and the pharmaceutical industry is no…
August 9, 2024

Read more

ThoughtSpot_Gaurav Gupta
THOUGHTSPOT

How Remote Patient Monitoring Technologies Are Transforming Healthcare Delivery

For decades, the traditional doctor's visit has been the cornerstone of healthcare delivery. Patients schedule appointments, travel to clinics, and wait to see a physician for a snapshot assessment of their health. But this model is undergoing a seismic shift. Remote patient monitoring (RPM) technologies are rapidly transforming how we monitor health, empowering patients and…
June 6, 2024

Read more

VIEWPOINTS_Meri Beckwith _2024
VIEWPOINTS

Infusing AI in Clinical Trials: Meri Beckwith from Lindus Health in Conversation with PharmaShots

Shots: Meri Beckwith, Co-Founder of Lindus Health engages in a striking conversation with PharmaShots Meri talks about bridging the gaps of clinical trials in CNS/Neurology by leveraging LLMs that are trained on nearly a million clinical trial protocols and simple machine learning models to monitor real-time clinical trial data Meri highlights the importance of multidisciplinary…
May 8, 2024

Read more

VIEWPOINTS_Raviv Pryluk_2024
VIEWPOINTS

Technology Infusion: Raviv Pryluk Sheds Light on PhaseV’s Recent Collaboration with 9xchange Biopharma Marketplace

Shots:  Raviv Pryluk, CEO and Co-Founder of PhaseV, in a stimulating conversation with PharmaShots, sheds light on the company’s recent partnership with 9xchange Biopharma   The partnership aims to bring Phase V’s proprietary machine learning (ML) technology to ecosystem members, enabling them, to retrospectively analyze and optimally design and execute advanced clinical studies  Raviv highlights the…
April 23, 2024

Read more

ThoughtSpot_Igor Zagradanin7
THOUGHTSPOT

Exploring the Impact of Multi-Modal Imaging Solutions

In an era prioritizing precision and profound insight, the advancement of imaging solutions has been truly remarkable. Starting from the rudimentary origins of X-ray technology to the intricate multi-modal imaging systems of today, the journey of visualizing the invisible has been characterized by unwavering innovation.Nonetheless, as the complexity of our inquiries escalates, the sophistication…
February 21, 2024

Read more

VIEWPOINTS_Betty Woo_2023
VIEWPOINTS

In an Insightful Conversation with PharmaShots, Betty Woo Highlights Thermo Fisher’s Cell Therapy Collaboration Program

Shots:  Betty Woo, VP of Cell, Gene, and Advanced Therapies, Thermo Fisher Scientific discusses the evolution of ThermoFisher’s strategic collaboration with ArsenalBio   Betty highlights the development of programmable autologous T cells for the treatment of cancer and the cell therapy collaboration program  Betty believes that through innovation and partnership, they can tap into the full…
November 30, 2023

Read more

VIEWPOINTS_Jane Reed_2023
VIEWPOINTS

Jane Reed Highlights the Growing Dependence of NLP to Comply with the Regulatory Guidelines

Shots: In an invigorating conversation with PharmaShots, Jane Reed discusses the transition from document-driven to data-driven decision-making in the pharmaceutical industry  Jane sheds light on the increasing dependence on AI and ML in regulatory affairs and how it helps pharma companies mitigate errors, discrepancies, and non-compliance  Jane highlights the benefits of NLP in ensuring regulatory…
November 16, 2023

Read more

Load more